This product is intended for research use only and is not suitable for human or veterinary use.
C8383
Chloral hydrate
Synonyme(s) :
Trichloroacetaldehyde hydrate
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
| Conditionnement | Référence | Disponibilité | Prix |
|---|
A propos de cet article
Formule linéaire :
Cl3CCH(OH)2
Numéro CAS:
Poids moléculaire :
165.40
UNSPSC Code:
51111800
NACRES:
NA.77
PubChem Substance ID:
EC Number:
206-117-5
Beilstein/REAXYS Number:
1698497
MDL number:
Le tarif et la disponibilité ne sont pas disponibles actuellement.
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderassay
≥98% (titration)
Quality Level
form
powder
drug control
USDEA Schedule IV
mp
57 °C (lit.)
SMILES string
OC(O)C(Cl)(Cl)Cl
InChI
1S/C2H3Cl3O2/c3-2(4,5)1(6)7/h1,6-7H
InChI key
RNFNDJAIBTYOQL-UHFFFAOYSA-N
Biochem/physiol Actions
Chloral hydrate is a sedative/hypnotic.
1 of 1
Cet article | |||
|---|---|---|---|
| form powder | form powder | form powder | form powder |
| assay ≥98% (titration) | assay ≥98% (HPLC) | assay ≥98% (HPLC and enzymatic) | assay ≥98% (HPLC) |
| drug control USDEA Schedule IV | drug control USDEA Schedule IIIN; regulated under CDSA - not available from Sigma-Aldrich Canada | drug control - | drug control - |
| Quality Level 200 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| mp 57 °C (lit.) | mp - | mp - | mp - |
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2
Classe de stockage
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Contenu apparenté
Jennifer Ngolab et al.
Acta neuropathologica communications, 8(1), 123-123 (2020-08-06)
An amendment to this paper has been published and can be accessed via the original article.
Xin Fang et al.
Journal of neurochemistry, 150(4), 441-452 (2019-03-10)
While glucagon-like peptide-1 (GLP-1) was reported to have a positive impact on Parkinson disease, it is extremely short half-life greatly hindered its clinical use. In this study, the mouse strain MG1363-pMG36e-GLP-1 was engineered to continuously express GLP-1 to treat Parkinson
Megan M Monsanto et al.
Nature communications, 11(1), 3955-3955 (2020-08-10)
Cellular therapy to treat heart failure is an ongoing focus of intense research, but progress toward structural and functional recovery remains modest. Engineered augmentation of established cellular effectors overcomes impediments to enhance reparative activity. Such 'next generation' implementation includes delivery
Numéro d'article de commerce international
| Référence | GTIN |
|---|---|
| C8383-1KG | 04061833522196 |
| C8383-250G | 04061832556277 |
| C8383-100G | 04061832556260 |
-
Are you able to dispense choral hydrate?
1 answer-
Helpful?
-